IW-3718

· Ironwood Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for IW-3718, covering 2016-08-01 to 2021-08-18. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) [Phase 3]

See pricing